1. A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease
- Author
-
Bruno De Bernardi, Katia Mazzocco, Stefania Sorrentino, Elvira Pota, Massimo Provenzi, Angela Rita Sementa, Anna Rita Gigliotti, Anna Maria Caroleo, Claudio Granata, Monica Muraca, and Stefano Avanzini
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Disease ,Systemic therapy ,Lesion ,Neuroblastoma ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Stage (cooking) ,Young adult ,Child ,Localized neuroblastoma ,Neoplasm Staging ,business.industry ,Infant, Newborn ,Clinical course ,Infant ,Adrenalectomy ,Hematology ,medicine.disease ,Oncology ,Child, Preschool ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Female ,medicine.symptom ,business ,Follow-Up Studies ,030215 immunology - Abstract
The authors describe a newborn diagnosed with localized neuroblastoma that evolved to stage 4s at the age of 5 months. Peculiar features of the case included a bilateral adrenal primary, the skin as the only metastatic site, and the development of a muscular lesion late in the clinical course. The patient underwent left adrenalectomy and all other lesions regressed without further therapy. The case prompted a search for similar cases both in the Italian Neuroblastoma Registry and in the literature. All patients identified, although variously treated, survived with the exception of the 2 with MYCN gene amplification. We conclude that infants with neuroblastoma who undergo a transition from a localized to stage 4s disease could be less rare than expected. In the absence of unfavorable biology, a wait-and-see policy with strict follow-up could be adopted for these patients, avoiding potentially damaging systemic therapy.
- Published
- 2019
- Full Text
- View/download PDF